Trial
NCT01234298
SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Shire
Collaborators
—
Condition
Negative Symptoms of Schizophrenia
Intervention
SPD489 Low-Dose
Why stopped
Study was discontinued due to non-safety related business prioritization decisions
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-03